Catalog #SUR10
Survodutide
10 MG
Currently Out of Stock
This item is currently out of stock. You can still order — expect 7 to 10 business days for delivery.
Not yet available
This research material is being prepared for release. It is not currently available for purchase. Research use only. Not for human or animal use. Not for injection.
Related Laboratory Supply
Laboratory Research Diluent — 0.9% Benzyl Alcohol is available separately for qualified laboratory workflows. Research use only. Not for human or animal use. Not for injection, diagnostic, clinical, therapeutic, or veterinary use.
View Laboratory Research Diluent →Technical Research Description
Survodutide is a dual glucagon and GLP-1 receptor agonist featuring balanced activity at both receptors. This dual mechanism enables research into combined effects on hepatic glucose production, energy expenditure, and lipid metabolism beyond what single-receptor agonists can achieve.
Simplified Explanation
Survodutide activates both glucagon and GLP-1 receptors at the same time. This unique combination allows it to influence both blood sugar control and fat metabolism. Researchers study how activating these two pathways together creates effects neither can produce alone.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Customer Reviews
No reviews yet — be the first to share your experience.
From Our Research Blog
Background reading and laboratory context for Survodutide 10 MG — sourced from our research articles.
research
Survodutide and the GLP-1/Glucagon Research Split
Survodutide pairs GLP-1 and glucagon receptor agonism in one peptide. Here's what preclinical work suggests, and what to measure n…
Jul 8, 2026
research
AOD-9604 fragment research: what's known so far
AOD-9604 is a short hGH-derived fragment studied for metabolic signaling. Here's what preclinical data suggests, plus practical la…
Jul 30, 2026
research
LC-120 Lipotropic Research Blend for Hepatic Lipid Flux
LC-120 is a ready-to-use lipotropic blend for in-vitro work on hepatic lipid transport, choline metabolism, and methionine-cycle b…
Jul 23, 2026
research
Tirzepatide: A dual incretin tool for metabolic work
Tirzepatide is a dual GIP/GLP-1 receptor agonist used in preclinical metabolic studies. Here's what to measure, control, and compa…
Jul 16, 2026
research
Hexarelin growth hormone secretagogue research: basics
A practical, research-first look at hexarelin: receptor pharmacology, GH/IGF-1 signaling in models, and common experimental readou…
Jul 14, 2026